Amedisys, Inc.
AMED
$100.99
$0.010.01%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -53.97% | 399.36% | -220.52% | -47.65% | 124.31% |
| Total Depreciation and Amortization | 0.12% | 0.14% | -0.29% | 3.78% | 1.28% |
| Total Amortization of Deferred Charges | -21.77% | 0.00% | 0.00% | 0.40% | -0.40% |
| Total Other Non-Cash Items | 140.07% | -160.63% | 702.08% | -46.71% | 16.35% |
| Change in Net Operating Assets | 122.76% | -297.11% | -61.74% | 1,098.03% | 85.39% |
| Cash from Operations | 1,922.92% | -105.25% | -33.46% | 101.94% | 899.65% |
| Capital Expenditure | 42.39% | -9.46% | 19.86% | 0.00% | 48.13% |
| Sale of Property, Plant, and Equipment | -73.33% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -29.31% | -2.35% | 83.96% | -469.89% | 53.27% |
| Cash from Investing | 32.97% | -7.34% | 47.65% | -55.63% | 48.79% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -0.66% | -1.22% | -2.98% | 0.99% | -5.59% |
| Issuance of Common Stock | -39.78% | -57.92% | 151.14% | -- | -- |
| Repurchase of Common Stock | -9.67% | -118.29% | -103.41% | 81.97% | -479.90% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -24.08% | -61.19% | 90.60% | -388.41% | -205.26% |
| Cash from Financing | -4.26% | -18.70% | 25.73% | -7.15% | -64.68% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 385.51% | -131.77% | -34.40% | 140.33% | 301.85% |